Table 2.

The HIF1-α expression according to clinicopathological features.

	Average	Standard deviation	Minimum	Lower quartile	Median	Upper quartile	Maximum	P
FIGO stage
IA	6.31	3.30	0	4	6	9	12	NS
IB	6.82	2.74	3	4	6	9	12
II	5.14	1.46	3	4	6	6	8
IIIA	7.20	2.35	4	6	8	8	12
IIIC	5.65	3.10	0	4	6	8	12
IVB	4.33	2.34	0	4	5	6	6
Grading
1	5.86	3.48	2	4	4	9	12	NS
2	6.25	2.77	0	4	6	8	12
3	5.50	2.83	0	4	6	8	9
Bokhman subtype
1	5.56	2.29	0	4	6	6	12	0.0115
2	7.64	3.67	0	6	7	12	12
Lymph node metastases
0	6.30	2.77	0	4	6	8	12	NS
1	5.39	2.92	0	4	6	6	12
Distant metastases
0	6.19	2.82	0	4	6	8	12	NS
1	4.33	2.34	0	4	5	6	6
Myometrial invasion >50%
0	6.38	3.07	0	4	6	9	12	NS
1	5.57	2.33	0	4	6	6	12
Cervical infiltration
0	6.21	3.07	0	4	6	9	12	NS
1	5.87	2.46	0	4	6	8	12
Infiltration of adnexa
0	6.05	2.81	0	4	6	8	12	NS
1	6.18	3.03	0	4	6	8	12
Risk of recurrence
Low	4.90	2.15	0	4	5	6	9	0.0434
Intermediate and high	6.40	2.91	0	4	6	8	12